MicrobiologybioRxivPreprint
Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE-2 in vitro
K. Khanna, W. Raymond, J. Jin…·J. V. Fahy
Thiol drugs inhibit SARS-CoV-2 infection in vitro and reduce lung injury in vivo, supporting their potential as COVID-19 treatments.
DOI 10.1101/2020.12.08.415505